The detection of WT1 gene expression in peripheral blood of acute leukemia patients with fluorescence quantitative RT-PCR
Chang-fu Nie
Abstract
Chang-fu Nie
Abstract
Objective To understand WT1 gene expression levels in peripheral blood of acute leukemia patients.Methods Fluorescence quantitative reverse transcription polymerase chain reaction (FQ-RT-PCR) method was established for detecting WT1 gene expression levels in peripheral blood in 114 patients with acute leukemia, 26 non-leukemia patients and 36 normal human with PE ABI 7700 PCR.Results The expression levels of WT1 in newly diagnosed leukemia patients (22 AML and 15 ALL)were 10 5~10 6 copies /μg RNA; those of 26 AML and 19 ALL with partial remission were 10 2~10 4 copies /μg RNA; those of 17 AML and 13 AL with complete remission were 0~10 2 copies /μg RNA.Conclusion Significant expression levels of WT1 in acute leukemia were strikingly higher than in non-leukemia and normal human which were undetectable or lower expression. WT1 can be a marker for detecting minimal residual disease and evaluating therapy efficacy in leukemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To understand WT1 gene expression levels in peripheral blood of acute leukemia patients.Methods Fluorescence quantitative reverse transcription polymerase chain reaction (FQ-RT-PCR) method was established for detecting WT1 gene expression levels in peripheral blood in 114 patients with acute leukemia, 26 non-leukemia patients and 36 normal human with PE ABI 7700 PCR.Results The expression levels of WT1 in newly diagnosed leukemia patients (22 AML and 15 ALL)were 10 5~10 6 copies /μg RNA; those of 26 AML and 19 ALL with partial remission were 10 2~10 4 copies /μg RNA; those of 17 AML and 13 AL with complete remission were 0~10 2 copies /μg RNA.Conclusion Significant expression levels of WT1 in acute leukemia were strikingly higher than in non-leukemia and normal human which were undetectable or lower expression. WT1 can be a marker for detecting minimal residual disease and evaluating therapy efficacy in leukemia.
Key concepts: Leukemia, Minimal residual disease, Real-time polymerase chain reaction, Acute leukemia, Peripheral blood, Gene, Reverse transcription polymerase chain reaction, Polymerase chain reaction